Challenges in lung cancer screening in Latin America Article

Raez, LE, Nogueira, A, Santos, ES et al. (2018). Challenges in lung cancer screening in Latin America . 2018(4), 10.1200/JGO.17.00040

cited authors

  • Raez, LE; Nogueira, A; Santos, ES; Dos Santos, RS; Franceschini, J; Ron, DA; Block, M; Yamaguchi, N; Rolfo, C



  • Lung cancer is the deadliest cancer worldwide and is of particular concern for Latin America. Its rising incidence in this area of the world poses myriad challenges for the region's economies, which are already struggling with limited resources to meet the health care needs of low- and middle-income populations. In this environment, we are concerned that regional governments are relatively unaware of the pressing need to implement effective strategies for the near future. Low-dose chest computed tomography (LDCT) for screening, and routine use of minimally invasive techniques for diagnosis and staging remain uncommon. According to results of the National Lung Screening Trial, LDCT lung cancer screening provided a 20% relative reduction in mortality rates among at-risk individuals. Nevertheless, this issue is still a matter of debate, particularly in developing countries, and it is not fully embraced in developing countries. The aim of this article is to provide an overview of what the standard of care is for lung cancer computed tomography screening around the world and to aid understanding of the challenges and potential solutions that can help with the implementation of LDCT in Latin America.

publication date

  • March 1, 2018

Digital Object Identifier (DOI)


  • 2018


  • 4